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active compounds having anti-diabetic and lipid lowering properties.
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Introduction: The study was conducted to assess the hypolipidemic and hypoglycemic effects 
of Nelumbo nucifera flowers powder in Long-Evans rats.
Methods: Experimental rats were made hyperlipidemic and diabetic (type 2) by feeding high 
fat diet (Lab diet, Dalda and Coconut oil = 4: 3: 1) and injecting alloxan respectively. N. nucifera 
flowers powder in different percentages was mixed with the regular Lab Diet for 21 days feeding. 
Serum total cholesterol, triglyceride, low-density lipoprotein (LDL), high-density lipoprotein 
(HDL) and blood glucose levels were evaluated in various groups.
Results: Feeding with N. nucifera flowers powder at different percentages to hyperlipidemic 
groups showed diverse but a significant (P < 0.05) decrease in serum total cholesterol, triglyceride 
and LDL-cholesterol levels when compared to control group while HDL-cholesterol level was 
increased significantly (P < 0.05). Routine feeding with N. nucifera flowers powder for 21 days 
resulted in significant decrease in the blood glucose levels of alloxan-induced diabetic rats. Both 
20% and 10% of N. nucifera flower powders with Lab Diet significantly (P < 0.05) decreased 
blood glucose level up to 48% and 34%, respectively in comparison to the drug control group 
treated with glibenclamide which was found with the decreasing capability up to 66% where 
the higher percentage of N. nucifera flower powder was found to exert more prominent effect 
in lowering blood glucose level. During comparison to the control group, the above mentioned 
percentages of N. nucifera flowers powder was found to reduce the blood glucose level around 
32.05% and 47.92% respectively. Although not prominent, but the data revealed that the sample 
was endowed with the body weight declining capability. 
Conclusion: Results of the experiments affirm that the flower of N. nucifera has potent 
hypoglycemic and hypolipidemic properties and might be useful in these patients.
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Introduction
Lipid abnormalities are generally connected with 
diabetes which ultimately is considered as one of the 
most contributory factors for cardiovascular morbidity 
and mortality in patients suffering from diabetes. Type 
II diabetes is the most common one which accounts for 
about 90% of the diabetic population affecting minimum 
15 million people. It is directly connected with other 
difficulties including hypertension, atherosclerosis and 
microcirculatory disorders. Among all the endocrine 
disorders, diabetes mellitus (type 2) is highly reported 
and is projected that almost three hundred million will 
be affected by the disease by 2025 and greater portion 
of diabetic population will be from India, China and 
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United States (1-6). According to recent epidemiological 
studies, in Bangladesh more than 11% diabetic patients 
are suffered from type II diabetes and the presence of 
atypical fasting glucose, which triggers the initiation of 
diabetes, goes beyond 6% in Dhaka city (7). Therefore, 
it is now inevitable to search for novel oral drugs that 
will be therapeutically effective both as hypoglycemic 
and hypolipidemic agents at affordable cost particularly 
both for the developing and under-developed countries. 
In the experiments of hypoglycemic effects evaluation, 
animals are made diabetic usually by injecting alloxan 
or streptozotocin (STZ) intraperitoneally (IP) or 
intravenously (IV). For the studies of hypolipidemic 
activity, the subjected animals are generally fed with high 
fat diet to produce hyperlipidemia in those animals.
Nelumbo nucifera is an aquatic perennial which belongs to 
the family of Nelumbonaceae and is familiar by many local 
names (e.g. Indian lotus, Chinese water lily, and Sacred 
lotus). Lotus flowers powder is utilized in traditional 
medicine to treat high blood pressure, diarrhea, fever, 
weakness, infection, skin inflammation, and body heat 
imbalance (8). It is also an effective treatment against 
abnormal bleeding such as hematemesis, epistaxis, 
hemoptysis, hematuria, and metrorrhagia (9). Lotus 
flowers extracts are found to possess a powerful 
antioxidant and radical scavenging ability along with 
inhibitory activity of diabetic complications (10-13). Lotus 
flower extract has been reported to treat obesity, too (14-
16). Furthermore, lotus flowers extracts were observed 
to modulate lipolysis-activity and decrease adipogenesis 
in human pre-adipocytes (17) as well as to increase 
cholesterol profile in mice and reduce levels of phospho-
lipids and triglycerides (18). It is notable to mention that 
anti-HIV principles have also been constructed using the 
ethanolic extract of the lotus flowers (19). This study was 
conducted to assess the hypolipidemic and hypoglycemic 
effects of N. nucifera flowers powder in Long-Evans rats.
Materials and Methods 
Experimental design
This experiment was conducted according to Figure 1.
The study was carried out in Biomedical and Toxicological 
Research Institute (BTRI), Bangladesh Council for 
Scientific and Industrial Research (BCSIR), Dhaka, 
Bangladesh. Flowers of N. nucifera were brought from 
National Botanical Garden, Mirpur, Dhaka, Bangladesh 
and identified by the Bangladesh National Herbarium, 
Dhaka. At first, the flowers of N. nucifera were washed 
vigorously using water and then dried at room temperature. 
The flowers were then air dried and subsequently oven 
dried at 37°C temperature. Later on, the dried flowers 
were grinded to powder form which then screened to 
find out the fine powder. Powder size of <0.5 mm after 
passing through a 35-mesh sieve was considered for the 
experiment.
Healthy male rats (Long-Evans) of local strain, having 
around 150-200 g and 200-250 g weights were taken for 
the hypolipidemic and hypoglycemic effects studies, 
respectively. The proper environmental condition for 
the experimental rats was confirmed, kept under firm 
supervision for a week and maintained at a constant room 
temperature of 25°C ± 5°C with humidity of 40% to 70% 
 
ethanolic extract of the lotus flowers (19). This study was conducted to assess the hypolipidemic and 
hypoglycemic effects f N. nucifera flowers powder in Long-Evans rats. 
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Flowchart 1: Experimental design Figure 1. Experiment l design.
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with natural day-night cycle.
For the hypolipidemic effect studies, the rats were 
segregated into a total of eight groups consisting of six 
in each maintaining the congruity of body weight. These 
included:
Group-A (feeding with lab diet).
Group-B1 (feeding with 10% powder of N. nucifera flower 
and 90% lab diet).
Group-B2 (feeding with 20% powder of N. nucifera flower 
and 80% lab diet).
Group-B3 (feeding with 30% powder of N. nucifera flower 
and 70% lab diet).
Group-C (feeding with high fat diet after inducing 
hyperlipidemia). 
Group-D1 (feeding with 10% powder of N. nucifera flower 
and 90% high fat diet after inducing hyperlipidemia).
Group-D2 (feeding with 20% powder of N. nucifera flower 
and 80% high fat diet after inducing hyperlipidemia).
Group-D3 (feeding with 30% powder of N. nucifera flower 
and 70% high fat diet after inducing hyperlipidemia).
For evaluation of hypoglycemic activity of N. nucifera 
flower, the rats were segregated into five groups comprising 
of six in each with the congruence of body weight. These 
included:
1) Group-A (Normal Control, rats fed with 100% lab diet)
2) Group-B (Alloxan induced diabetic rats fed with 100% 
lab diet, diabetic control).
3) Group-C (Alloxan induced diabetic rats fed with Lab 
Diet plus glibenclamide, given at a dose of 5 mg/10 mL 
(9.9 mL H2O + 0.1 mL Twin 20)/kg body weight, drug 
control (23).
4) Group-D (Alloxan induced diabetic rats fed with 10% 
powder of N. nucifera flower plus 90% lab diet).
5) Group-E (Alloxan induced diabetic rats fed with 20% 
powder of N. nucifera flower plus 80% lab diet).
Before starting the experiment, the weights of the rats 
were taken precisely and the rats were marked on the 
tail, right front, right back, left front, left back and kept 
unmark which was subsequently applied as identification 
purpose for a particular rat, so that the reaction of a 
specific rat before and after the drug administration could 
be observed individually.
Preparation of hyperlipidemic rats and estimation of the 
lipid profile
The rats were made hyperlipidemic by feeding high fat 
diet for 10 days containing Lab Diet, Dalda and Coconut 
oil in 4ː3:1 ratio. 
For evaluation of hypolipidemic activity, the powder of 
the N. nucifera flower was administered orally with high 
fat diet and lab diet at doses of daily 10%, 20% and 30% of 
the regular diet for 21 days.
Blood samples were collected on the 22nd day by 
sacrificing the rats after making anesthesia using ketamine 
hydrochloride. After sacrificing about 2 mL of blood was 
taken cautiously. The blood samples were then centrifuged 
after 20 minutes at 4000 rpm for 10 minutes and re-
centrifuged at 2000 rpm for 5 minutes. After that the 
serums samples were separated and taken into Eppendorf 
tubes. Then the serum triglyceride, total cholesterol, high-
density lipoprotein cholesterol (HDL-C) and low-density 
lipoprotein cholesterol (LDL-C) were measured. One 
milliliter of serum was aliquoted and kept frozen at -20°C 
until analysis of serum for lipid profile. 
Serum total cholesterol was measured by enzymatic 
colorimetric (Cholesterol Oxidase /Peroxidase, CHOD-
PAP) method (Randox Laboratories Ltd., UK) using 
autoanalyzer, AutoLab. Serum HDL-cholesterol was 
estimated by enzymatic colorimetric (Cholesterol CHOD-
PAP) method (Randox Laboratories Ltd., UK) using micro-
plate reader (Bio-Tec, ELISA) and Serum triglyceride 
(TG) was examined by enzymatic colorimetric (GPO-
PAP) method (Randox Laboratories Ltd., UK) using auto 
analyzer, Auto Lab. Then, serum LDL cholesterol was 
calculated manually. The calculated formula was:
( )
5
TGLDL C TC HDL C− = − + −
All the groups of rats were remained under similar 
environmental conditions and provided with the 
measured food and water throughout the experiment. The 
body weight of each rat was measured and compared with 
the controls.
Preparation of diabetic rats and measurement of blood 
glucose level
Alloxan monohydrate (C2H2N2O4.H2O) was available in 
colored bottles containing 25 g powder. The solution was 
prepared by dissolving 10 g in 100 mL of distilled water 
(10%).
The rats were made diabetic (diabetes mellitus) by 
injecting alloxan monohydrate 150-mg/kg-body weight 
intravenously (20). Three days after injection of the 
alloxan monohydrate, blood glucose of all the surviving 
rats was determined by the Diagnostics EliTech method. 
The rats with blood glucose levels above 6 mmol/L were 
considered as diabetic and considered for further study.
For the assessment of hypoglycemic effect, N. nucifera 
flowers powder was fed orally with Lab Diet at doses of 
daily 10% and 20% of regular diet for 21 days. The drug, 
glibenclamide was administrated orally as a drug control, 
at a dose of 5 mg/10 mL (9.9 mL H2O + 0.1 ml Twin 20)/
kg body weight to the respective grouped rats.
Fasting blood glucose level was measured using glucometer 
on the 3rd (initial), 12th and 22nd days by collecting 
blood samples nicking the lateral tail vein using a sterile 
scalpel blade under ketamine hydrochloride anesthesia. 
Just before cutting, the tail was immersed into warm water 
(40°C) for around 25 seconds for vasodilatation.
Data analysis
The data analysis was performed using SPSS. 11.5 
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windows program. P < 0.05 was considered significant. 
For charts and graphical representation Microsoft Word 
and Microsoft Excel were used.
Results
During the entire study period laboratory protocols 
described in Materials and Methods section were followed 
strictly. The findings based on experimental data are 
depicted below:
Chronic effect of Nelumbo nucifera flower powder on 
body weight of rats
Chronic effect of N. nucifera flower powder on body weight 
of normal control rats fed with lab diet and rats fed with lab 
diet plus sample
The impacts of N. nucifera flowers powder on body weight 
of the rats during 21 days of feeding with Lab Diet plus 
sample in different percentages are shown in Table 1. Body 
weight of each rat was measured at every 11-day intervals 
and compared with that of the normal control group fed 
with 100% Lab Diet.
Chronic effect of Nelumbo nucifera flower powder on body 
weight of hyperlipidemic model rats fed with high fat diet 
plus sample in comparison to hyperlipidemic model rats fed 
with only high fat diet
The impacts of N. nucifera flower powder on body weight 
of hyperlipidemic rats administered with 100% high 
fat diet and the grouped rats fed with high fat diet plus 
sample at various percentages during 21 days of feeding 
are delineated in Table 2. Body weight of each rat was 
measured at every 11-day intervals.
Chronic effects of Nelumbo nucifera flower powder on 
lipid status (total cholesterol & triglyceride) of rats
Chronic effects of Nelumbo nucifera flower powder on 
lipidemic status (total cholesterol & triglyceride) of rats fed 
with Lab Diet plus sample in comparison to normal control 
rats fed with lab diet
The mean serum total cholesterol and triglyceride levels of 
normal control rats administered with lab diet and model 
rats, administered with Lab Diet plus N. nucifera flowers 
powder for 21 days followed by blood collection on 22nd 
day are presented in Table 3. To find out whether there 
was a statistically significant difference in hypolipidemia 
obtained by the powder sample on the 22nd day.
Chronic effect of Nelumbo nucifera flowers powder 
on lipidemic status (total cholesterol & triglyceride) of 
hyperlipidemic rats fed with high fat diet Plus Sample in 
comparison to hyperlipidemic model rats fed with only high 
fat diet
The mean serum total cholesterol and triglyceride levels 
of high fat diet treated hyperlipidemic rats administered 
with only high fat diet (treated as control) and model rats 
administered with high fat diet plus powder of N. nucifera 
flower for 21 days followed by blood collection on 22nd 
day are presented in Table 4.
Chronic effect of Nelumbo nucifera flower powder on 
lipidemic status (HDL-C and LDL-C) of rats
Chronic effect of Nelumbo nucifera flower powder on 
lipidemic status (HDL-C and LDL-V) of rats fed with lab 
diet plus sample in comparison to normal control rats fed 
with lab diet
The effect of N. nucifera flower powder on atherogenic 
Table 1. Chronic effect of Nelumbo nucifera flower powder on body weight (BW) of rats fed with lab diet plus sample in comparison to normal control 
rats fed with lab diet
Group BW, Initial day (g) BW, 12th day (g) BW, 22nd day (g)
Group A (100% high diet) (n=6) 174.17±8.04 (100%) 178.17±7.78 (102.30%) 183.17±7.31 (105.18%)
Group B (lab diet + sample) B1 (90% lab diet + 10% sample) (n=6) 172±7.04 (100%) 173.83±7.68 a (101.06%) 176±7.82 a (102.33%)
B2 (80% lab diet + 20% sample) (n=6) 171.17±6.43 (100%) 172.83±6.11 a (100.97%) a 174.83±6.11 a (102.12%)
B3 (70% lab diet + 30% sample) (n=6) 172.67±6.19 (100%) 174.50±6.09 a (101.06%) 174.83±5.67 a (101.25%)
Data are presented as Mean ± SD and compared using one-way ANOVA (Duncan post hoc test), n = number of rats. 
a Statistically significant in comparison to the control group (P < 0.05).
Table 2. Chronic effect of Nelumbo nucifera flower powder on body weight (BW) of hyperlipidemic rats fed with high fat diet plus sample in 
comparison to hyperlipidemic rats fed with only high fat diet
Group BW, Initial day (g) BW, 12th day (g) BW, 22nd day (g)
Group C (100% high fat diet (n=6) 172.33±10.46 176.83±10.52 180.33±9.63
Group D (high fat diet + sample) B1 (90% lab diet + 10% sample) (n=6) 171.67±11.00 172.20±11.62 a 172.14±12.58 a
B2 (80% lab diet + 20% sample) (n=6) 171.50±8.17 172.58±7.06 a 172.59±7.17 a
B3 (70% lab diet + 30% sample) (n=6) 174±5.93 174.88±5.47 a 174.79±5.92 a
Data are presented as Mean ± SD and compared using one-way ANOVA (Duncan post hoc test), n = number of rats. 
a Statistically significant in comparison to the control group (P < 0.05).
Journal of Herbmed Pharmacology, Volume 7, Number 3, July 2018            http://www.herbmedpharmacol.com152 
Islam et al
lipids (HDL-C and LDL-V) of rats fed with lab diet plus 
sample and normal control rats fed with lab diet is shown 
in Table 5.
Chronic effect of Nelumbo nucifera flowers powder on 
lipidemic status (HDL-C and LDL-V) of high fat diet 
induced hyperlipidemic rats fed with high fat diet plus 
sample in comparison to hyperlipidemic rats fed with only 
high fat diet
The effect of N. nucifera flower powder on atherogenic 
lipids (HDL-C and LDL-V) is presented in Table 6.
Chronic effect of Nelumbo nucifera flowers powder on 
fasting blood glucose concentration of alloxan induced 
type 2 diabetic model rats
The effects of N. nucifera flower powder 10% with 90% 
Lab Diet and 20% with 80% Lab Diet, expressed as change 
in blood glucose level, are depicted in Table 7. Fasting 
blood glucose level of each rat was taken at every 11-day 
intervals.
Discussion
It is obvious that there was a tendency to decline the body 
weight in all sample fed rat groups whereas normal control 
rats displayed increase in body weights at the end of study 
period (Table 1). Mathematically around a maximum 
0.90% body weight reduction was observed in comparison 
to the body weights measured at first day considered as 
100%.
It is noticed from the data presented in Table 2 that there 
was a raise in body weight in each group. But the sample 
administered groups displayed slower enhancement 
in body weight than high fat diet fed groups. Data also 
suggest that after feeding of only high fat diet for 21 days, 
body weight augmentation was almost maximum of 10% 
if the initial body weight was considered as 100%. But, 
when along with the high fat diet, the sample at different 
percentages was given, the body weight increase was only 
a maximum of 0.20% considering the initial body weight 
as 100%.
According to data presented in Table 3, a significant 
diminution (P < 0.05) of TC and TG values in group B1 
(90% lab diet + 10% sample), group B2 (80% lab diet + 
20% sample) and group B3 (70% lab diet + 30% sample) 
compared to group A (100% Lab Diet) was observed and 
this diminution was more significant in higher percent of 
Table 3. Chronic effects of Nelumbo nucifera flower powder on lipidemic status (total cholesterol & triglyceride) of rats fed with lab diet plus sample 
in comparison to normal control rats fed with lab diet
Group BW, Initial day (g) BW, 12th day (g) BW, 22nd day (g)
Group C (100% high fat diet) (n=6) 172.33±10.46 (100%) 176.83±10.52 (102.61%) 180.33±9.63 (104.64%)
Group D (high fat 
diet + sample)
D1 (90% high fat diet + 10% sample) (n=6) 171.67±11.00 (100%) 172.20±11.62 a (100.31%) 172.14±12.58 a (100.27%)
D2 (80% high fat diet + 20% sample) (n=6) 171.50±8.17 (100%) 172.58±7.06 a (100.58%) 172.59±7.17 a (100.64%)
D3 (70% high fat diet + 30% sample (n=6) 174±5.93 (100%) 174.88±5.47 a (100.51%) 174.79±5.92 a (100.45%)
Data are presented as Mean ± SD and compared using one-way ANOVA (Duncan post hoc test), n = number of rats. 
a Statistically significant in comparison to the control group (P < 0.05).
Table 4. Chronic effect of Nelumbo nucifera flowers powder on lipidemic status (total cholesterol & triglyceride) of hyperlipidemic rats fed with high 
fat diet plus sample in comparison to hyperlipidemic model rats fed with only high fat diet
Group TC, 22nd day (mg/dL) TG, 22nd day (mg/dL)
Group C (100% high fat diet) (n=6) 119.33±11.13 100.83±18.49
Group D (high fat diet + sample)
D1 (90% high fat diet + 10% sample) (n=6) 85.17±9.26 a 89.83±16.39 a
D2 (80% high fat diet + 20% sample) (n=6) 72.67±8.14 a 83±15.28 a
D3 (70% high fat diet + 30% sample)(n=6) 60.17±8.18 a 77.83±14.16 a
Data are presented as mean ± SD and compared using one-way ANOVA (Duncan post hoc test), n = number of rats. 
a Statistically significant in comparison to the control group (P < 0.05).
Table 5. Chronic effect of Nelumbo nucifera flower powder on lipidemic status (HDL-C and LDL-C) of rats fed with lab diet plus sample in comparison 
to normal control rats fed with lab diet
Group HDL-C, 22nd day LDL-C, 22nd day
Group A (100% lab diet) (n=6) 55.50±4.42 16.85±2.44
Group B (lab diet + sample)
B1 (90% lab diet + 10% sample) (n=6) 69.83±7.91 a 9.00±1.21 a
B2 (80% lab diet + 20% sample) (n=6) 76±9.78 a 8.33±1.08 a
B3 (70% Lab diet + 30% sample) (n=6) 80.83±9.70 a 7.28±1.01 a
Data are presented as mean ± SD and compared using one-way ANOVA (Duncan post hoc test), n = number of rats. 
a Statistically significant in comparison to the control group (P < 0.05).
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Sample treated groups. Data reveal that the TC and TG 
values of the highest percentage sample treated group, 
group B3 in comparison to the group A after 21 days of 
feeding, were found to be lowered by around 43% and 
44%, respectively.
Data shown in Table 4, confirm that samples have the 
characteristics of TC and TG diminishing abilities at a 
significant level in comparison to that of control one.
In Table 5, significant variations were observed in the 
HDL-C and LDL-C levels among all the test groups after 
21 days of sample treatment. In case of group B3 (70% 
lab diet + 30% sample) HDL-cholesterol was mostly 
augmented compared to the group A (100% lab diet). In 
Groups B1 (90% lab diet + 10% sample) and B2 (80% lab 
diet + 20% sample) the HDL-C levels were also found to 
be augmented in a significant level although lower than 
group B3. Furthermore, LDL-C level was observed to be 
reduced significantly in all the studies groups. Among all 
the groups, group B3 (70% lab diet + 30% sample) was 
found with the lowest level of LDL-C. In group B3, the 
HDL-C level was observed to be augmented by almost 
49% and the LDL-C level was found to be reduced to 60% 
in comparison to that of group A after 21 days of sample 
treatment.
It was found according to data presented in Table 6 that, 
overall, HDL-C level increased significantly while that 
of LDL-C decreased which was also significant among 
all the studied groups after 21 days of chronic trial. The 
lipidemic profile was checked on 22nd day of the study. 
In case of group D3 (70% lab diet + 30% sample) HDL-C 
level was found to be increased maximum compared to 
the group C (100% lab diet). It is worth mentioning that 
in case of group D1 (90% lab diet + 10% sample) and 
group D2 (80% lab diet + 20% sample) the HDL-C level 
was also observed to be augmented significantly while 
LDL-C level in all experimental groups was found to be 
decreased significantly. More specifically, in case of group 
D3 where the maximum of around 48% of HDL-C level 
was observed to be increased and the highest of 62% of 
LDL-C level seen to be reduced in comparison to that of 
group C.
It is worth mentioning from Table 5 and Table 6 that the 
increase of HDL cholesterol level was prominently higher 
in sample diet fed groups compared to that of normal 
control groups (both group A and group C). Significantly 
increment tendency of HDL cholesterol level was observed 
with the higher percentage of sample diet. It is also clear 
from Table 5 and Table 6 that the reduction of LDL 
cholesterol level was higher with the higher percentage 
of sample diet which surely implies to the hypolipidemic 
activities of the sample, N. nucifera flowers powder.
In Table 7, blood glucose levels were depicted and more 
significant (P < 0.05) anti-diabetic activity was observed on 
22nd day in alloxan induced type 2 diabetic model rats. In 
a study it has been suggested that a 25% reduction in blood 
glucose level is considered a significant hypoglycemic 
effect. The results of the study were satisfactory and 
revealed that the 10% & 20% N. nucifera flowers powder 
exhibited significant (P < 0.05) hypoglycemic activity. In 
case of 10% sample induced group, the reduction of blood 
glucose level was 33%. The reduction of blood glucose 
level in alloxan induced rat was found highest, 44% with 
the N. nucifera of 20%.
Conclusion
According to the experimental results, it can be affirmed 
that N. nucifera flowers powder is endowed with strong 
hypoglycemic and hypolipidemic properties. Therefore, 
powder of N. nucifera flower may be utilized for the 
management of diabetes mellitus and other related 
complications directly linked to the lipid disorders. On 
the whole, N. nucifera is a very promising herbal plant 
Table 6. Chronic effect of Nelumbo nucifera flower powder on lipidemic status (HDL-C and LDL-C) of high fat diet induced hyperlipidemic model 
rats fed with high fat diet plus sample in comparison to hyperlipidemic model rats fed with only high fat diet
Group HDLC, 22nd day LDLC, 22nd day
Group C (100% high fat diet) (n=6) 50.67±2.42 21.20±4.53
Group D (high fat diet + sample)
D1 (90% high fat diet + 10% sample) (n=6) 75±7.46 a 14.03±2.54 a
D2 (80% high fat diet + 20% sample) (n=6) 79±6.90 a 12±1.92 a
D3 (70% high fat diet + 30% sample) (n=6) 89.17±5.42 a 9.60±1.16 a
Data are presented as mean ± SD and compared using one-way ANOVA (Duncan post hoc test), n = number of rats. 
a Statistically significant in comparison to the control group (P < 0.05).
Table 7. Chronic effect of Nelumbo nucifera flower powder on fasting blood glucose (FBG) concentration of alloxan induced type 2 diabetic model 
rats
Group FBG, initial day (mmol/L) FBG, 12th day (mmol/L) FBG, 22nd day (mmol/L)
Group-A (normal control) 4.80 ± 0.51 (100%) 4.76 ± 0.43 (99.17%) 4.74 ± 0.39 (98.75%)
Group-B (diabetic control) 15.42 ± 0.23 (100%) 15.38 ± 0.18 (99.74%) 15.64 ± 0.25 (101.43%)
Group-C (drug control) 15.50 ± 0.28 (100%) 9.41 ± 0.38 a (60.71%) 5.32 ± 0.16 a (34.32%)
Group-D (sample 10% + lab diet 90%) 15.07 ± 0.47 (100%) 11.49 ± 0.87 a (76.24%) 10.24 ± 0.96 a (67.95%)
Group-E (sample 20% + lab diet 80%) 15.13 ± 0.58 (100%) 9.76 ± 0.57 a (64.51%) 7.88 ± 0.33 a (52.08%)
Data are presented as mean ± SD and compared using one-way ANOVA (Duncan post hoc test), n = number of rats. 
a Statistically significant in comparison to the control group (P < 0.05).
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having enormous medicinal values. The plant should be 
examined vigorously to find out for its active ingredients 
for which hypoglycemic and hypolipidemic activities are 
being exerted and mode of actions behind the observed 
effects.
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